Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
If you travel frequently for work, consider booking before each trip
Use consistently for 23 months for best results
Excretion Pathways Radiolabeled studies in humans established PT-141s elimination pathways: 64.8% of administered dose recovered in urine 22.8% of dose recovered in feces Complete elimination occurring within several days No evidence of accumulation with repeated administration The predominantly renal excretion pattern and absence of accumulation support the approved dosing regimen of no more than one dose per 24 hours and maximum eight doses per month
December 2023: Judge James Cain, Jr
Safety, Eligibility, and Provider-Guided Decision-Making Adverse event data in humans is sparse
The mean eosinophilic granulocyte count of CAR was significantly higher (14%) over time as compared to that of CON (p=0.002) and also the mean percentage of eosinophils of CAR was 11% higher (p=0.049) than that of CON ( Supplementary Table 1 )
